Pfizer is betting on cancer drugs to recover from a COVID business slump
Pfizer is pushing to be more involved in cancer drugs after a tumultuous year marked by a rapid decline in business due to COVID. During a four-hour investor event last week, Pfizer pushed its initiative to “accelerate breakthroughs that help people with cancer worldwide live better and longer,” according to CNBC. The drugmaker has ramped …
Pfizer is betting on cancer drugs to recover from a COVID business slump Read More »